Skip to content
Press Release
FEATURED | September 11, 2025

Jason Chambers Headlines the Melanoma Research Fou...

Superyacht Captain, TV Personality, Melanoma Patient and Advocate Poised to Emcee Event Honoring the Melanoma Community  New York City, NY (September 11, 2025) – The...

4 Minute Read
September 29, 2025

Leveraging GSDMD-Mediated Pyroptosis as a Therap...

Dan Erkes‘s Abstract Melanoma is the most lethal skin cancer, leading to an estimated 8,290 deaths and 100,640 new cases in 2024. Melanoma was traditionally ...

3 Minute Read
September 29, 2025

VISTA-Positive Neutrophils in Melanoma Immunothera...

Daniel Hirschhom‘s Abstract Immunotherapy has greatly improved survival for people with melanoma, but many patients also experience harmful side effect...

1 Minute Read
September 29, 2025

Mapping the Death and Growth of Tumor Cells in Mel...

Kenneth Hu‘s Abstract Immunotherapies including immune checkpoint blockade (ICB) have seen remarkable success in the clinic. Unfortunately, many patients with late-st...

3 Minute Read
September 29, 2025

Investigating the Role of Cancer-Associated Fibrob...

Emily Bernstein‘s Abstract Melanoma is the most lethal skin cancer, and the success of current therapies remains limited. To better tailor melanoma treatments, we m...

2 Minute Read
September 29, 2025

Pedigree Approach to Identify Predisposition Varia...

Lisa Cannon-Albright‘s Abstract Analysis of large families with more disease than expected has been shown to be a powerful way to identify cancer predisposition g...

2 Minute Read
September 29, 2025

Next-Generation RAF-Targeting Strategies for RAS-M...

Mathieu Desaunay‘s Abstract Skin cancer is one of the most common types of cancer, with melanoma being the deadliest form. In the United States, approximately 104,9...

3 Minute Read
September 29, 2025

Transforming therapy for Acral and Mucosal Melanom...

Mona Foth‘s Abstract Acral and mucosal melanomas(A&MM) are rare but aggressive types of melanoma, making up less than 5% of all cases. Unlike the more common typ...

2 Minute Read
September 29, 2025

Redirecting Antiviral Immune Responses to Elimina...

Thorsten Mempel‘s Abstract While immunotherapy has greatly improved the survival for patients with melanoma of the sun-exposed skin, especially for those with adva...

3 Minute Read
September 29, 2025

Overcoming Drug Resistance in NRAS-Mutant Melanoma...

Hee Won Yang‘s Abstract Melanoma is an aggressive type of skin cancer known for its rapid spread and frequent resistance to current treatments. Many advanced melanoma...

1 Minute Read
September 29, 2025

 Inhibiting ligand-driven BMP Signaling to Overco...

Craig Ceol‘s Abstract The use of immunotherapies has revolutionized treatment for late-stage melanoma patients. These therapies have extended survival for many patien...

3 Minute Read
July 11, 2025

A/B Testing of Patient Decision Aids for Dysplasti...

Jaclyn Roland-McGowan’s Abstract This research project explores how different versions of a patient decision aid can help people make informed choices about their ski...

1 Minute Read
July 10, 2025

Inhibiting Myeloid-derived Suppressor Cells Improv...

Emma Clark’s Abstract Melanoma is a disease that places an incredible physical, financial, and emotional burden upon our society. Treatment options for melanoma have ...

1 Minute Read

Oct 16, 2025 ET

Ask the Expert: Mucosal Melanoma – Current and Emerging Treatments, Research and Patient Perspectives

Oct 16, 2025 ET

5th Annual #GetNakedJax

Oct 18, 2025 ET

San Diego Miles for Melanoma 5K

Oct 25, 2025 ET

CURE OM Global Science Meeting

Oct 30, 2025 ET

Ask The Expert: Minimal Residual Disease Testing in Melanoma Management

Oct 30, 2025 ET

24th Annual New York Gala

Nov 02, 2025 ET

Atlanta Miles for Melanoma 5K

Explore Events